Sometimes infections can mean bigger financial returns, argues Michael L. Millenson.
In Health Affairs this morning, Michael L. Millenson waxes passionately about the flaws of a healthcare system in which preventable hospital harms still too often occur. And he takes hospital administrators to task by asking if their institutions actually profit when mistakes, such as central-line-associated bloodstream infections, happen. “Do we believe in ‘First, do no harm’? or ‘First, do no unprofitable harm,’ even if it means blurring the moral boundary between filling hospital beds with those we’re trying to help and those who we have just hurt?” he asks.
Millenson, an internationally recognized expert on patient safety, notes that we near the 20th anniversary of the landmark Institute of Medicine study To Err Is Human and, although some improvement seems to have occurred-for instance, every hospital in the country is doing something to reduce preventable harms-he nonetheless loads his opinion piece with links to studies that still tell a somewhat disheartening tale. You can check them out here, here, here, here, and here.
Millenson isn’t blaming hospital administrators, per se, but says that too often it is easier for infection control to become a somewhat routine and dangerously dysfunctional effort. Providers don’t escape blame, either.
Millenson: “As a study of clinician overconfidence in infection control delicately concluded, providers ‘do not recognize the need for training [for themselves] but express this need for others.’ In that context, we perhaps should not be surprised that 40% of respondents to a recent
nationwide survey’ on hospital safety culture agreed that ‘hospital management seems interested in patient safety only after an adverse event happens.’”
Millenson acknowledges some push-back, noting that the Society for Healthcare Epidemiology of America in 2007 made the case that its members didn’t just add to costs but that there’s a genuine “business case for infection control. A dozen years later, infection control specialists still feel they need ‘an administrative champion,’” Millenson writes.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.